CRBP
Corbus Pharmaceuticals Holdings, Inc.Recent alerts on CRBP
All signals →
SEC filing
CRBP Appoints Evercore Exec Nishant Saxena CBO, Pre-2026 ASCO Data Shows CRB-701 Durable Responses in HNSCC, Cervical Cancer; CRB-913 Phase 1b Complete
12d ago
SEC filing
CRBP Amends Exec Agreements: Cohen Base $673.6K, 60% Bonus Target, 2-Yr Term; Moran Base $501.3K, 40% Bonus Target, 2-Yr Term
46d ago
SEC filing
CRBP Reports $75M Offering, $19.3M Net Income, +94% YoY, CRB-701 47.6% ORR, CRB-913 2.9% Weight Loss
85d ago
Insider trade
Sale by Dominic Smethurst (Chief Medical Officer)
89d ago
Insider trade
Sale by Sean F. Moran
103d ago
Insider trade
Sale by Dominic Smethurst (Chief Medical Officer)
104d ago
Insider trade
Sale by Ian Hodgson (Chief Operating Officer)
104d ago
News
Corbus Pharmaceuticals Announces Pricing of Public Offering
153d ago
News
Corbus Pharmaceuticals Announces Pricing of Public Offering
153d ago
Scanner
Unusual volume (z=39.8)
171d ago
Get push alerts for CRBP
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS